Display options
Cite
Scott NA, Moga C, Harstall C, et al. Using health technology assessment to identify research gaps: an unexploited resource for increasing the value of clinical research. Healthc Policy. 2008;3(3):e109-27
Scott, N. A., Moga, C., Harstall, C., & Magnan, J. (2008). Using health technology assessment to identify research gaps: an unexploited resource for increasing the value of clinical research. Healthcare policy = Politiques de sante, 3(3), e109-27.
Scott, N Ann, et al. "Using health technology assessment to identify research gaps: an unexploited resource for increasing the value of clinical research." Healthcare policy = Politiques de sante vol. 3,3 (2008): e109-27.
Scott NA, Moga C, Harstall C, Magnan J. Using health technology assessment to identify research gaps: an unexploited resource for increasing the value of clinical research. Healthc Policy. 2008 Feb;3(3):e109-27. PMID: 19305759; PMCID: PMC2645140.
Copy Download .nbib Format: NLM
Share it on

Healthc Policy. 2008 Feb;3(3):e109-27.

Using health technology assessment to identify research gaps: an unexploited resource for increasing the value of clinical research.

Healthcare policy = Politiques de sante

N Ann Scott, Carmen Moga, Christa Harstall, Jacques Magnan

Affiliations

  1. Research Associate, Health Technology Assessment Unit, Institute of Health Economics, Edmonton, AB.

PMID: 19305759 PMCID: PMC2645140

Abstract

Health technology assessments (HTAs) are an as yet unexploited source of comprehensive, systematically generated information that could be used by research funding agencies to formulate researchable questions that are relevant to decision-makers. We describe a process that was developed for distilling evidence gaps identified in HTAs into researchable questions that a provincial research funding agency can use to inform its research agenda. The challenges of moving forward with this initiative are discussed. Using HTA results to identify research gaps will allow funding agencies to reconcile the different agendas of researchers who conduct clinical trials and healthcare decision-makers, and will likely result in more balanced funding of pragmatic and explanatory trials. This initiative may require a significant cultural shift from the current, mostly reactive, funding environment based on an application-driven, competitive approach to allocating scarce research resources to a more collaborative, contractual one that is proactive, targeted and outcomes-based.

References

  1. Ann Behav Med. 2006 Feb;31(1):5-13 - PubMed
  2. Bull World Health Organ. 2000;78(8):1054-61 - PubMed
  3. BMC Med Res Methodol. 2003 Dec 22;3:28 - PubMed
  4. Bull World Health Organ. 1998;76(2):127-33 - PubMed
  5. BMJ. 1997 Mar 15;314(7083):817-20 - PubMed
  6. Int J Technol Assess Health Care. 2001 Summer;17(3):433-41 - PubMed
  7. Int J Technol Assess Health Care. 2004 Winter;20(1):11-24 - PubMed
  8. Health Technol Assess. 2004 Jul;8(31):1-103, iii - PubMed
  9. Nat Mater. 2003 Oct;2(10):639 - PubMed
  10. Pharmacoeconomics. 2006;24(11):1055-68 - PubMed
  11. Bull World Health Organ. 1998;76(1):17-24 - PubMed
  12. Circulation. 1994 Nov;90(5):2192-3 - PubMed
  13. N Engl J Med. 2003 Aug 28;349(9):868-74 - PubMed
  14. Milbank Q. 2003;81(3):363-88 - PubMed
  15. JAMA. 2003 Sep 24;290(12):1624-32 - PubMed
  16. BMJ. 2001 Aug 4;323(7307):275-9 - PubMed
  17. J Clin Epidemiol. 2006 Nov;59(11):1125-6 - PubMed
  18. BMJ. 1996 Nov 30;313(7069):1390-3 - PubMed
  19. BMJ. 1998 Jan 24;316(7127):285 - PubMed
  20. Int J Technol Assess Health Care. 1989;5(3):333-9 - PubMed
  21. Eur Heart J. 1997 Mar;18(3):367-70 - PubMed
  22. Pharmacoeconomics. 2006;24(11):1143-56 - PubMed

Publication Types